Toshihiko Aibiki

1.0k total citations
17 papers, 417 citations indexed

About

Toshihiko Aibiki is a scholar working on Epidemiology, Hepatology and Physiology. According to data from OpenAlex, Toshihiko Aibiki has authored 17 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Hepatology and 5 papers in Physiology. Recurrent topics in Toshihiko Aibiki's work include Liver Disease Diagnosis and Treatment (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Nutrition and Health in Aging (5 papers). Toshihiko Aibiki is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Nutrition and Health in Aging (5 papers). Toshihiko Aibiki collaborates with scholars based in Japan and United States. Toshihiko Aibiki's co-authors include Hideki Miyata, Tomoyuki Ninomiya, Yoshifumi Suga, Tomonari Okudaira, Atsushi Hiraoka, Kojiro Michitaka, Nobuaki Azemoto, Hiroka Yamago, Tomoe Kawamura and Masashi Hirooka and has published in prestigious journals such as Journal of Gastroenterology and Hepatology, Journal of Gastroenterology and European Journal of Radiology.

In The Last Decade

Toshihiko Aibiki

14 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toshihiko Aibiki Japan 9 258 234 159 64 60 17 417
Yoshifumi Suga Japan 8 255 1.0× 229 1.0× 149 0.9× 64 1.0× 63 1.1× 16 412
Tomonari Okudaira Japan 10 263 1.0× 238 1.0× 159 1.0× 67 1.0× 64 1.1× 20 442
Tomoe Kawamura Japan 9 244 0.9× 234 1.0× 84 0.5× 102 1.6× 93 1.6× 20 404
Hidetaro Ueki Japan 6 174 0.7× 165 0.7× 77 0.5× 64 1.0× 62 1.0× 11 300
Shirin Feshtali Netherlands 10 119 0.5× 107 0.5× 149 0.9× 82 1.3× 148 2.5× 24 357
Soichi Iritani Japan 8 115 0.4× 99 0.4× 197 1.2× 74 1.2× 63 1.1× 15 324
Takumi Akiyama Japan 12 249 1.0× 272 1.2× 82 0.5× 163 2.5× 119 2.0× 25 534
Hideomi Tomida Japan 11 176 0.7× 204 0.9× 79 0.5× 262 4.1× 84 1.4× 34 582
Shunji Koya Japan 10 83 0.3× 81 0.3× 154 1.0× 21 0.3× 47 0.8× 19 243
Akiko Toshimori Japan 10 85 0.3× 67 0.3× 70 0.4× 165 2.6× 42 0.7× 24 313

Countries citing papers authored by Toshihiko Aibiki

Since Specialization
Citations

This map shows the geographic impact of Toshihiko Aibiki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshihiko Aibiki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshihiko Aibiki more than expected).

Fields of papers citing papers by Toshihiko Aibiki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshihiko Aibiki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshihiko Aibiki. The network helps show where Toshihiko Aibiki may publish in the future.

Co-authorship network of co-authors of Toshihiko Aibiki

This figure shows the co-authorship network connecting the top 25 collaborators of Toshihiko Aibiki. A scholar is included among the top collaborators of Toshihiko Aibiki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshihiko Aibiki. Toshihiko Aibiki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Adachi, Tomoko, Atsushi Hiraoka, Hidenori Okazaki, et al.. (2020). Exacerbation of psoriasis vulgaris by sorafenib treatment for hepatocellular carcinoma. Clinical Journal of Gastroenterology. 13(5). 891–895. 4 indexed citations
2.
Hiraoka, Atsushi, Hirofumi Izumoto, Tomoko Adachi, et al.. (2019). SARC‐F combined with a simple tool for assessment of muscle abnormalities in outpatients with chronic liver disease. Hepatology Research. 50(4). 502–511. 14 indexed citations
3.
Hiraoka, Atsushi, Hirofumi Izumoto, Hidetaro Ueki, et al.. (2019). Easy surveillance of muscle volume decline in chronic liver disease patients using finger‐circle (yubi‐wakka) test. Journal of Cachexia Sarcopenia and Muscle. 10(2). 347–354. 22 indexed citations
4.
Yamago, Hiroka, Atsushi Hiraoka, Hirofumi Izumoto, et al.. (2019). Ultrasonography surveillance improves prognosis of patients with hepatocellular carcinoma. Molecular and Clinical Oncology. 11(3). 325–330. 1 indexed citations
5.
Hiraoka, Atsushi, Kojiro Michitaka, Hirofumi Izumoto, et al.. (2018). Relative changes in handgrip strength and skeletal muscle volume in patients with chronic liver disease over a 2‐year observation period. Hepatology Research. 48(7). 502–508. 11 indexed citations
6.
Michitaka, Kojiro, Atsushi Hiraoka, Toshihiko Aibiki, et al.. (2018). A case of valproate-induced hyperammonemia due to carnitine deficiency who responded well to levocarnitine therapy. Kanzo. 59(8). 421–426. 1 indexed citations
7.
Hiraoka, Atsushi, Hidetaro Ueki, Miho Kaneto, et al.. (2016). A resected hepatic neuroendocrine carcinoma with elevation of AFP and fucosylated AFP. Kanzo. 57(8). 397–404. 2 indexed citations
8.
Hiraoka, Atsushi, Kojiro Michitaka, Hidetaro Ueki, et al.. (2016). Sarcopenia and two types of presarcopenia in Japanese patients with chronic liver disease. European Journal of Gastroenterology & Hepatology. 28(8). 940–947. 49 indexed citations
9.
Azemoto, Nobuaki, Hideki Miyata, Hidetaro Ueki, et al.. (2016). A case of unilocular serous cystadenoma in which preoperative diagnosis was difficult. Suizo. 31(4). 654–661.
10.
Michitaka, Kojiro, Eiji Tsubouchi, Toshihiko Aibiki, et al.. (2016). High fever and arrhythmia that emerged after drinking alcohol in a patient with chronic hepatitis C under treatment with ledipasvir/sofosbuvir. Kanzo. 57(11). 586–591.
11.
Hiraoka, Atsushi, Yoshihiro Ishimaru, Hideki Kawasaki, et al.. (2015). Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization. Oncology. 89(3). 167–174. 33 indexed citations
12.
Hiraoka, Atsushi, Toshihiko Aibiki, Tomonari Okudaira, et al.. (2015). Muscle atrophy as pre-sarcopenia in Japanese patients with chronic liver disease: computed tomography is useful for evaluation. Journal of Gastroenterology. 50(12). 1206–1213. 81 indexed citations
13.
Hiraoka, Atsushi, Rie Matsuda, Toshihiko Aibiki, et al.. (2015). Ultrasonography screening for hepatocellular carcinoma in Japanese patients with diabetes mellitus. Journal of Diabetes. 8(5). 640–646. 14 indexed citations
14.
Hiraoka, Atsushi, Toshihiko Aibiki, Tomonari Okudaira, et al.. (2015). A case of hepatic angiosarcoma treated with paclitaxel. Kanzo. 56(8). 428–434. 1 indexed citations
15.
Hiraoka, Atsushi, Takashi Kumada, Kojiro Michitaka, et al.. (2015). Usefulness of albumin–bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 31(5). 1031–1036. 158 indexed citations
16.
Hiraoka, Atsushi, Tomoe Kawamura, Toshihiko Aibiki, et al.. (2014). Prognosis and therapy for ruptured hepatocellular carcinoma: Problems with staging and treatment strategy. European Journal of Radiology. 84(3). 366–371. 26 indexed citations
17.
Hiraoka, Atsushi, Yusuke Imai, Toshihiko Aibiki, et al.. (2014). Clinical features of fatty liver in nonobese Japanese without regular alcohol intake. Diabetology International. 6(1). 60–65.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshifumi Suga Breakdown of academic impact, for papers by Tomonari Okudaira Breakdown of academic impact, for papers by Tomoe Kawamura Breakdown of academic impact, for papers by Hidetaro Ueki Breakdown of academic impact, for papers by Shirin Feshtali Breakdown of academic impact, for papers by Soichi Iritani Breakdown of academic impact, for papers by Takumi Akiyama Breakdown of academic impact, for papers by Hideomi Tomida Breakdown of academic impact, for papers by Shunji Koya Breakdown of academic impact, for papers by Akiko Toshimori
Rankless by CCL
2026